EUVIMEDEUVIMED entdecken
Crossref

Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer’s disease

Feiya Sheng, Jia-Mei Yu, Qiao Yang, Rigu Jipei, Wen-Qi Xie, Gu Zhan, Yan Zhang, Le-Le Zhang iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgag105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Feiya Sheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Preclinical Medicine, Chengdu University, No. 2025 Chengluo Avenue, Chengdu, Sichuan 610106, China. Hauptthemen laut MEDLINE: Reishi, Alzheimer Disease, Neuroprotective Agents, Neuroinflammatory Diseases. Die Arbeit nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Open Research Project of Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to explore the anti-neuroinflammatory mechanism of Ganoderma lucidum against Alzheimer’s disease (AD) using network pharmacology and molecular docking, and verify its neuroprotective and anti-neuroinflammatory effects in Aβ1–42-induced AD mice.

Methods

Common targets were screened and analyzed by KEGG/GO enrichment. Core targets were evaluated by molecular docking and dynamics simulation. Aβ1–42-induced AD mice and LPS-stimulated macrophages were used. Cognitive function, Aβ deposition, tau phosphorylation, and inflammatory gene expression were measured. Key findings Network analysis highlighted inflammation-related pathways. Molecular dynamics simulations confirmed stable binding between active components and targets like STAT1, STAT3, JAK2, and TNF. In vivo, G. lucidum extract suppressed abnormal activation of microglia and astrocytes, and reduced pro-inflammatory factors. Following G. lucidum administration, mRNA levels of Jak2 and Stat1 in hippocampal tissue were significantly reduced, suggesting potential regulation of neuroinflammation via the JAK2/STAT1 pathway. Concurrently, G. lucidum down-regulated transcription of key subunits (Ncstn, Aph-1, Pen-2) in the γ-secretase complex, thereby reducing Aβ1–42 production. In vitro experiments similarly confirmed G. lucidum’s ability to inhibit LPS-induced IL-6 and TNF-α release from macrophages.

Conclusions

Ganoderma lucidum extract alleviates neuroinflammation in AD models, providing experimental evidence for its potential application in AD prevention or therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReishiAlzheimer DiseaseNeuroprotective AgentsNeuroinflammatory DiseasesAnti-Inflammatory AgentsAnimalsMiceJanus Kinase 2Amyloid beta-PeptidesSTAT1 Transcription FactorMolecular Docking SimulationNetwork PharmacologyMaleHippocampusDisease Models, AnimalMicrogliaMacrophagesPeptide FragmentsMolecular Dynamics SimulationSignal Transduction

Stichwörter der Autor:innen

Ganoderma lucidumAlzheimer’s diseaseAβ1–42network pharmacologyneuroinflammation

Substanzen

Janus Kinase 2Amyloid beta-PeptidesSTAT1 Transcription FactorNeuroprotective AgentsAnti-Inflammatory AgentsJak2 protein, mouseStat1 protein, mouseamyloid beta-protein (1-42)Peptide Fragments

Autor:innen und Institutionen

  • School of Preclinical Medicine, Chengdu University, No. 2025 Chengluo Avenue, Chengdu, Sichuan 610106, China.
  • Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, Chengdu University of Traditional Chinese Medicine, No. 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan 6111…
  • College of Pharmacy, Chengdu University, No. 2025 Chengluo Avenue, Chengdu, Sichuan 610106, China.

ORCID-Profile: Le-Le Zhang

Förderung

  • National Natural Science Foundation of China
  • Open Research Project of Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province

Zitieren

APA

Sheng, F., Yu, J. M., Yang, Q., Jipei, R., Xie, W. Q., Zhan, G., Zhang, Y., & Zhang, L. L. (2026). Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer’s disease. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag105

Vancouver

Sheng F, Yu JM, Yang Q, Jipei R, Xie WQ, Zhan G, et al. Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer’s disease. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag105

BibTeX
@article{Sheng2026,
  author = {Sheng, Feiya and Yu, Jia-Mei and Yang, Qiao and Jipei, Rigu and Xie, Wen-Qi and Zhan, Gu and Zhang, Yan and Zhang, Le-Le},
  title = {Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer’s disease},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgag105}
}
Kostenlos starten →